Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model
Kislay Roy,1 Rupinder K Kanwar,1 Subramanian Krishnakumar,2,3 Chun Hei Antonio Cheung,4 Jagat R Kanwar1 1Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), Molecular and Medical Research (MMR) Strategic Research Centre, School of Medicine (SoM), Faculty of H...
Guardado en:
Autores principales: | Roy K, Kanwar RK, Krishnakumar S, Cheung CH, Kanwar JR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1bcbf37790d246138ee4845c61119880 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanoformulated cell-penetrating survivin mutant and its dual actions
por: Sriramoju B, et al.
Publicado: (2014) -
Molecular targets in arthritis and recent trends in nanotherapy
por: Roy K, et al.
Publicado: (2015) -
Neurobehavioral burden of multiple sclerosis with nanotheranostics
por: Sriramoju B, et al.
Publicado: (2015) -
Oral administration of iron-saturated bovine lactoferrin–loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism
por: Mahidhara G, et al.
Publicado: (2015) -
Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers
por: Kamalapuram SK, et al.
Publicado: (2016)